Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Cystoid Macular Edema

Retina

Volumn 38, Issue 2, 2018, Pages 416-423

  Mansour, Ahmad M ^a,b   Sheheitli, Huda ^b   Kucukerdonmez, Cem ^c   Sisk, Robert A ^d   Moura, Raphael ^e   Moschos, Marilita M ^f   Lima, Luiz H ^e   Al Shaar, Laila ^b   Arevalo, J Fernando ^g   Maia, Mauricio ^e   Foster, Robert E ^d   Kayikcioglu, Ozcan ^h   Kozak, Igor ⁱ   Kurup, Shree ^j   Zegarra, Hernando ^k   Gallego Pinazo, Roberto ^l   Hamam, Rola N ^b   Bejjani, Riad A ^m   Cinar, Esat ^c   Erakgün, Ethem T ⁿ   Kimura, Alan ^o   Teixeira, Anderson ^p   more..

^a RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c IZMIR UNIVERSITY   (Turkey)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF ATHENS   (Greece)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h CELAL BAYAR UNIVERSITY   (Turkey)

ⁱ KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k Retina Associates of Cleveland   (United States)

^l HOSPITAL UNIVERSITARIO LA FE   (Spain)

^m SAINT JOSEPH UNIVERSITY   (Lebanon)

ⁿ Ekol Hospital   (Turkey)

^o UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^p UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

more..

Author keywords

cystoid macular edema; dexamethasone implant; intraocular pressure; retinitis pigmentosa

Indexed keywords

DEXAMETHASONE; FLUORESCENT DYE; GLUCOCORTICOID;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CATARACT; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OUTCOME ASSESSMENT; PSEUDOPHAKIA; RETINA MACULA CYSTOID EDEMA; RETINITIS PIGMENTOSA; RETROSPECTIVE STUDY; STEROID THERAPY; THERAPY RESISTANCE; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DOSE RESPONSE; DRUG EFFECT; DRUG IMPLANT; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA MACULA LUTEA; TIME FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

ADOLESCENT; ADULT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; RETINITIS PIGMENTOSA; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 85013469748     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000001542     Document Type: Article

References (28)

1. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 1998; 17: 175-205.
2. Liew G, Moore AT, Webster AR, Michaelides M. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2015; 56: 1531-1536.
3. Chung H, Hwang JU, Kim JG, Yoon YH. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa. Retina 2006; 26: 922-927.
4. Kim YJ, Joe SG, Lee DH, et al. Correlations between spectraldomain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013; 54: 1303-1309.
5. Sandberg MA, Brockhurst RJ, Gaudio AR, et al. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2005; 46: 3349-3354.
6. Artunay O, Yuzbasioglu E, Rasier R, et al. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. J Ocul Pharmacol Ther 2009; 25: 545-550.
7. Siqueira RC, Messias A, Voltarelli JC, et al. Resolution of macular oedema associated with retinitis pigmentosa after intravitreal use of autologous BM-derived hematopoietic stem cell transplantation (letter). Bone Marrow Transplant 2013; 48: 612-613.
8. Saraiva VS, Sallum JM, Farah ME. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2003; 34: 398-400.
9. Sacchetti M, Mantelli F, Merlo D, Lambiase A. Systematic review of randomized clinical trials on safety and efficacy of pharmacological and nonpharmacological treatments for retinitis pigmentosa. J Ophthalmol 2015; 2015: 737053.
10. Guadagni V, Novelli E, Piano I, et al. Pharmacological approaches to retinitis pigmentosa: a laboratory perspective. Prog Ret Eye Res 2015; 48: 62-81.
11. Buchaim G, Rezende MP, Maia M. Implante intravítreo de liberação crônica de dexametasona (Ozurdex-) para o tratamento de edema macular por retinose pigmentar: relato de caso [in Portuguese]. Arq Bras Oftalmol 2013; 76: 377-379.
12. Ahn SJ, Kim KE, Woo SJ, Park KH. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 160-164.
13. Srour M, Querques G, Leveziel N, et al. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2013; 251: 1501-1506.
14. Saatci AO, Selver OB, Seymenoglu G, Yaman A. Bilateral intravitreal dexamethasone implant for retinitis pigmentosarelated macular edema. Case Rep Ophthalmol 2013; 4: 53-58.
15. Alhassan M, Quintyn JC. Unilateral intravitreal dexamethasone implant for bilateral retinitis pigmentosa-related macular edema. Graefes Arch Clin Exp Ophthalmol 2013; 251: 2827-2828.
16. Patil L, Lotery AJ. Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant. Eye (Lond) 2014; 28: 449-451.
17. Haller JA, Bandello F, Belfort R Jr, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011; 118: 2453-2460.
18. Barge S, Rothwell R, Sepúlveda P, Agrelos L. Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema. Case Rep Ophthalmol Med 2013; 2013: 591681.
19. Urban KE, Quiram PA, Trese MT. Subretinal triamcinolone acetonide associated with improvement of cystoid macular edema in a patient with retinitis pigmentosa. Retin Cases Brief Rep 2009; 3: 47-49.
20. Scorolli L, Morara M, Meduri A, et al. Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone. Arch Ophthalmol 2007; 125: 759-764.
21. Wang C, Hu J, Bernstein PS, et al. Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases. Adv Exp Med Biol 2006; 572: 309-314.
22. Kim JE. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa. Retina 2006; 26: 1094-1096.
23. Minnella AM, Falsini B, Bamonte G, et al. Optical coherence tomography and focal electroretinogram evaluation of cystoid macular edema secondary to retinitis pigmentosa treated with intravitreal triamcinolone: case report. Eur J Ophthalmol 2006; 16: 883-886.
24. Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol Scand 2005; 83: 248-251.
25. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 1999; 127: 565-573.
26. Yoshida N, Ikeda Y, Notomi S, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 2013; 120: 100-105.
27. Adamus G, Wang S, Kyger M, et al. Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats. Mol Vis 2012; 18: 2323-2337.
28. Kohno H, Chen Y, Kevany BM, et al. Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal. J Biol Chem 2013; 288: 15326-15341.